Cargando…

Early Detection of Poor Adherers to Statins: Applying Individualized Surveillance to Pay for Performance

BACKGROUND: Medication nonadherence costs $300 billion annually in the US. Medicare Advantage plans have a financial incentive to increase medication adherence among members because the Centers for Medicare and Medicaid Services (CMS) now awards substantive bonus payments to such plans, based in par...

Descripción completa

Detalles Bibliográficos
Autores principales: Zimolzak, Andrew J., Spettell, Claire M., Fernandes, Joaquim, Fusaro, Vincent A., Palmer, Nathan P., Saria, Suchi, Kohane, Isaac S., Jonikas, Magdalena A., Mandl, Kenneth D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817130/
https://www.ncbi.nlm.nih.gov/pubmed/24223977
http://dx.doi.org/10.1371/journal.pone.0079611
_version_ 1782478023432339456
author Zimolzak, Andrew J.
Spettell, Claire M.
Fernandes, Joaquim
Fusaro, Vincent A.
Palmer, Nathan P.
Saria, Suchi
Kohane, Isaac S.
Jonikas, Magdalena A.
Mandl, Kenneth D.
author_facet Zimolzak, Andrew J.
Spettell, Claire M.
Fernandes, Joaquim
Fusaro, Vincent A.
Palmer, Nathan P.
Saria, Suchi
Kohane, Isaac S.
Jonikas, Magdalena A.
Mandl, Kenneth D.
author_sort Zimolzak, Andrew J.
collection PubMed
description BACKGROUND: Medication nonadherence costs $300 billion annually in the US. Medicare Advantage plans have a financial incentive to increase medication adherence among members because the Centers for Medicare and Medicaid Services (CMS) now awards substantive bonus payments to such plans, based in part on population adherence to chronic medications. We sought to build an individualized surveillance model that detects early which beneficiaries will fall below the CMS adherence threshold. METHODS: This was a retrospective study of over 210,000 beneficiaries initiating statins, in a database of private insurance claims, from 2008-2011. A logistic regression model was constructed to use statin adherence from initiation to day 90 to predict beneficiaries who would not meet the CMS measure of proportion of days covered 0.8 or above, from day 91 to 365. The model controlled for 15 additional characteristics. In a sensitivity analysis, we varied the number of days of adherence data used for prediction. RESULTS: Lower adherence in the first 90 days was the strongest predictor of one-year nonadherence, with an odds ratio of 25.0 (95% confidence interval 23.7-26.5) for poor adherence at one year. The model had an area under the receiver operating characteristic curve of 0.80. Sensitivity analysis revealed that predictions of comparable accuracy could be made only 40 days after statin initiation. When members with 30-day supplies for their first statin fill had predictions made at 40 days, and members with 90-day supplies for their first fill had predictions made at 100 days, poor adherence could be predicted with 86% positive predictive value. CONCLUSIONS: To preserve their Medicare Star ratings, plan managers should identify or develop effective programs to improve adherence. An individualized surveillance approach can be used to target members who would most benefit, recognizing the tradeoff between improved model performance over time and the advantage of earlier detection.
format Online
Article
Text
id pubmed-3817130
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38171302013-11-09 Early Detection of Poor Adherers to Statins: Applying Individualized Surveillance to Pay for Performance Zimolzak, Andrew J. Spettell, Claire M. Fernandes, Joaquim Fusaro, Vincent A. Palmer, Nathan P. Saria, Suchi Kohane, Isaac S. Jonikas, Magdalena A. Mandl, Kenneth D. PLoS One Research Article BACKGROUND: Medication nonadherence costs $300 billion annually in the US. Medicare Advantage plans have a financial incentive to increase medication adherence among members because the Centers for Medicare and Medicaid Services (CMS) now awards substantive bonus payments to such plans, based in part on population adherence to chronic medications. We sought to build an individualized surveillance model that detects early which beneficiaries will fall below the CMS adherence threshold. METHODS: This was a retrospective study of over 210,000 beneficiaries initiating statins, in a database of private insurance claims, from 2008-2011. A logistic regression model was constructed to use statin adherence from initiation to day 90 to predict beneficiaries who would not meet the CMS measure of proportion of days covered 0.8 or above, from day 91 to 365. The model controlled for 15 additional characteristics. In a sensitivity analysis, we varied the number of days of adherence data used for prediction. RESULTS: Lower adherence in the first 90 days was the strongest predictor of one-year nonadherence, with an odds ratio of 25.0 (95% confidence interval 23.7-26.5) for poor adherence at one year. The model had an area under the receiver operating characteristic curve of 0.80. Sensitivity analysis revealed that predictions of comparable accuracy could be made only 40 days after statin initiation. When members with 30-day supplies for their first statin fill had predictions made at 40 days, and members with 90-day supplies for their first fill had predictions made at 100 days, poor adherence could be predicted with 86% positive predictive value. CONCLUSIONS: To preserve their Medicare Star ratings, plan managers should identify or develop effective programs to improve adherence. An individualized surveillance approach can be used to target members who would most benefit, recognizing the tradeoff between improved model performance over time and the advantage of earlier detection. Public Library of Science 2013-11-04 /pmc/articles/PMC3817130/ /pubmed/24223977 http://dx.doi.org/10.1371/journal.pone.0079611 Text en © 2013 Zimolzak et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Zimolzak, Andrew J.
Spettell, Claire M.
Fernandes, Joaquim
Fusaro, Vincent A.
Palmer, Nathan P.
Saria, Suchi
Kohane, Isaac S.
Jonikas, Magdalena A.
Mandl, Kenneth D.
Early Detection of Poor Adherers to Statins: Applying Individualized Surveillance to Pay for Performance
title Early Detection of Poor Adherers to Statins: Applying Individualized Surveillance to Pay for Performance
title_full Early Detection of Poor Adherers to Statins: Applying Individualized Surveillance to Pay for Performance
title_fullStr Early Detection of Poor Adherers to Statins: Applying Individualized Surveillance to Pay for Performance
title_full_unstemmed Early Detection of Poor Adherers to Statins: Applying Individualized Surveillance to Pay for Performance
title_short Early Detection of Poor Adherers to Statins: Applying Individualized Surveillance to Pay for Performance
title_sort early detection of poor adherers to statins: applying individualized surveillance to pay for performance
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817130/
https://www.ncbi.nlm.nih.gov/pubmed/24223977
http://dx.doi.org/10.1371/journal.pone.0079611
work_keys_str_mv AT zimolzakandrewj earlydetectionofpooradhererstostatinsapplyingindividualizedsurveillancetopayforperformance
AT spettellclairem earlydetectionofpooradhererstostatinsapplyingindividualizedsurveillancetopayforperformance
AT fernandesjoaquim earlydetectionofpooradhererstostatinsapplyingindividualizedsurveillancetopayforperformance
AT fusarovincenta earlydetectionofpooradhererstostatinsapplyingindividualizedsurveillancetopayforperformance
AT palmernathanp earlydetectionofpooradhererstostatinsapplyingindividualizedsurveillancetopayforperformance
AT sariasuchi earlydetectionofpooradhererstostatinsapplyingindividualizedsurveillancetopayforperformance
AT kohaneisaacs earlydetectionofpooradhererstostatinsapplyingindividualizedsurveillancetopayforperformance
AT jonikasmagdalenaa earlydetectionofpooradhererstostatinsapplyingindividualizedsurveillancetopayforperformance
AT mandlkennethd earlydetectionofpooradhererstostatinsapplyingindividualizedsurveillancetopayforperformance